WO2010138873A8 - Long term expansion of human hematopoietic stem cells - Google Patents

Long term expansion of human hematopoietic stem cells Download PDF

Info

Publication number
WO2010138873A8
WO2010138873A8 PCT/US2010/036664 US2010036664W WO2010138873A8 WO 2010138873 A8 WO2010138873 A8 WO 2010138873A8 US 2010036664 W US2010036664 W US 2010036664W WO 2010138873 A8 WO2010138873 A8 WO 2010138873A8
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
hematopoietic stem
long term
human hematopoietic
hscs
Prior art date
Application number
PCT/US2010/036664
Other languages
French (fr)
Other versions
WO2010138873A1 (en
Inventor
Maroun Khoury
Adam C. Drake
Ilya B. Leskov
Jianzhu Chen
Original Assignee
Maroun Khoury
Drake Adam C
Leskov Ilya B
Jianzhu Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maroun Khoury, Drake Adam C, Leskov Ilya B, Jianzhu Chen filed Critical Maroun Khoury
Publication of WO2010138873A1 publication Critical patent/WO2010138873A1/en
Publication of WO2010138873A8 publication Critical patent/WO2010138873A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/17—Angiopoietin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C12N2502/1358—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Methods for culturing and increasing the number (expanding the population) of hematopoietic stem cells (HSCs) are provided. In one method, the HSCs are cocultured with mesenchymal stem cells (MSCs) in the presence of angiopoietin-like (Angplt5) growth factor, IGF-binding protein 2 (IGFBP2), stem cell factor (SCF), fibroblast growth factor (FGF), thrombopoietin (TPO), or a combination thereof. HSCs obtained by the methods described can be used in methods to repopulate an animal, such as an immunocompromised animal.
PCT/US2010/036664 2009-05-29 2010-05-28 Long term expansion of human hematopoietic stem cells WO2010138873A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21734409P 2009-05-29 2009-05-29
US61/217,344 2009-05-29

Publications (2)

Publication Number Publication Date
WO2010138873A1 WO2010138873A1 (en) 2010-12-02
WO2010138873A8 true WO2010138873A8 (en) 2011-01-20

Family

ID=43223112

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/036664 WO2010138873A1 (en) 2009-05-29 2010-05-28 Long term expansion of human hematopoietic stem cells

Country Status (1)

Country Link
WO (1) WO2010138873A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102343102A (en) * 2011-10-19 2012-02-08 柳忠辉 Application of activin receptor-interacting protein 2 (ARIP2) gene to preparation of medicament
CN110669792A (en) * 2019-10-23 2020-01-10 北京三有利和泽生物科技有限公司 Genetically modified mesenchymal stem cell, preparation method, application and cell therapy product

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2448967T3 (en) 2009-06-29 2015-07-20 Ilya B Leskov NON-HUMAN MAMMALS MODEL OF CANCER human hematopoietic
PT106225B (en) 2012-03-23 2017-11-03 Inst Superior Técnico EXCESSIVE EXPANSION PROCESS OF BIREMETICAL STEM CELLS
CA2868032A1 (en) * 2012-03-23 2013-09-26 Aastrom Biosciences, Inc. Cell compositions and methods of using same
US20160024473A1 (en) * 2013-03-08 2016-01-28 Cells For Cells Menstrual stems cells for the efficient support and expansion of cd34+ cd133+ hematopoietic stem cells in vitro
US10590387B2 (en) 2015-04-16 2020-03-17 The Board Of Regents Of The University Of Texas System CD133+ cells and method for expanding

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953662B2 (en) * 1997-08-29 2005-10-11 Human Genome Sciences, Inc. Follistatin-3
US7001766B2 (en) * 1999-07-20 2006-02-21 Curagen Corporation Nucleic acid sequences encoding human angiopoietin-like polypeptides
EP1874922A4 (en) * 2005-04-19 2009-10-28 Univ Johns Hopkins Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
WO2006127809A2 (en) * 2005-05-24 2006-11-30 Whitehead Institute For Biomedical Research Methods for expansion and analysis of cultured hematopoietic stem cells

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102343102A (en) * 2011-10-19 2012-02-08 柳忠辉 Application of activin receptor-interacting protein 2 (ARIP2) gene to preparation of medicament
CN110669792A (en) * 2019-10-23 2020-01-10 北京三有利和泽生物科技有限公司 Genetically modified mesenchymal stem cell, preparation method, application and cell therapy product

Also Published As

Publication number Publication date
WO2010138873A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
WO2010138873A8 (en) Long term expansion of human hematopoietic stem cells
WO2011011302A3 (en) Differentiation of human embryonic stem cells
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
HK1247954A1 (en) Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
WO2012135621A3 (en) Priming of pluripotent stem cells for neural differentiation
MY159971A (en) Multipotent/pluripotent cells and methods
WO2010059565A3 (en) Allografts combined with tissue derived stem cells for bone healing
EP1799812A4 (en) Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
EP2896690A3 (en) Use of RNA for reprogramming somatic cells
CA2863795A1 (en) Culturing of mesenchymal stem cells
WO2008148105A8 (en) Endometrial stem cells and methods of making and using same
WO2009134532A3 (en) Homing in mesenchymal stem cells
WO2009092005A3 (en) Methods of generating cardiomyocytes and cardiac progenitors and compositions
SG196784A1 (en) Stem cell cultures
EP1846548A4 (en) Methods of proliferating stem cells
HK1156976A1 (en) Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations
NZ630598A (en) Method of engrafting cells from solid tissues
WO2006047743A8 (en) Swine multipotent adult progenitor cells
WO2012098537A8 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
WO2008153366A3 (en) Method for manufacturing active recombinant blood coagulation factor ix
WO2014113704A3 (en) Enhanced differentiation of mesenchymal stem cells
WO2010022194A3 (en) Compositions and methods for generation of pluripotent stem cells
WO2007022348A3 (en) Amplification of cell polulations from embryonic stem cells
WO2009155041A3 (en) Method to modulate hematopoietic stem cell growth

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10781312

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10781312

Country of ref document: EP

Kind code of ref document: A1